Clinical trial
CARFILZOMIB IN COMBINATION WITH BENDAMUSTINE AND DEXAMETHASONE IN REFRACTORY OR RELAPSED MULTIPLE MYELOMA - A MULTICENTER PHASE IB/II TRIAL OF THE EUROPEAN MYELOMA NETWORK TRIALIST GROUP (EMNTG)
NCT02056756 is registered in ClinicalTrials.gov with Stichting European Myeloma Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CARFILZOMIB IN COMBINATION WITH BENDAMUSTINE AND DEXAMETHASONE IN REFRACTORY OR RELAPSED MULTIPLE MYELOMA - A MULTICENTER PHASE IB/II TRIAL OF THE EUROPEAN MYELOMA NETWORK TRIALIST GROUP (EMNTG)
- Lead sponsor
- Stichting European Myeloma Network
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- April 30, 2014
- Completion date
- January 30, 2023
- Enrollment
- 63 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.